XML 75 R22.htm IDEA: XBRL DOCUMENT

CONVERTIBLE DEBT	6 Months Ended	12 Months Ended
CONVERTIBLE DEBT	Jun. 30, 2024	Dec. 31, 2023
Aspire Biopharma Inc [Member]
Restructuring Cost and Reserve [Line Items]
CONVERTIBLE DEBT	NOTE 8 – CONVERTIBLE DEBT As of June 30, 2024 and December 31, 2023, the Company had no outstanding convertible debt.	NOTE 8 – CONVERTIBLE DEBT As of December 31, 2023, the Company had no outstanding convertible debt.

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details